Older patients with mantle cell lymphoma (MCL): Practice patterns and predictors of survival in the rituximab era.

被引：0

作者：

Karmali, Reem

Switchenko, Jeffrey M.

Goyal, Subir

Bachanova, Veronika

Gerson, James

Barta, Stefan K.

Danilov, Alexey Valeryevich

Grover, Natalie Sophia

Epperla, Narendranath

Burkart, Madelyn

Sawalha, Yazeed

Ghosh, Nilanjan

Bond, David Alan

Maddocks, Kami J.

Badar, Talha

Fenske, Timothy

Guo, Jin

Malecek, Mary-Kate

Martin, Peter

Cohen, Jonathon Brett

机构：

[1] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA

[2] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA

[3] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA

[4] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[5] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA

[6] Univ Minnesota, Minneapolis, MN USA

[7] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[8] Univ Penn, Philadelphia, PA 19104 USA

[9] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA

[10] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA

[11] Ohio State Univ, Columbus, OH 43210 USA

[12] Northwestern Mem Hosp, Chicago, IL 60611 USA

[13] Cleveland Clin, Cleveland, OH 44106 USA

[14] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA

[15] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA

[16] Ohio State Univ, Dept Internal Med, Div Hematol, Comprehens Canc Ctr, Columbus, OH 43210 USA

[17] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[18] Weill Cornell Med Coll, New York, NY USA

[19] Washington Univ, St Louis, MO 63110 USA

[20] New York Presbyterian Hosp, Weill Cornell Med, New York, NY USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期

基金：

美国国家卫生研究院;

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e20064

引用

页数：2

共 50 条

[41] Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma
Albertsson-Lindblad, Alexandra
Kolstad, Arne
Laurell, Anna
Raty, Riikka
Gronbaek, Kirsten
Sundberg, Jan
Pedersen, Lone Bredo
Ralfkiaer, Elisabeth
Karjalainen-Lindsberg, Marja-Liisa
Sundstrom, Christer
Ehinger, Mats
Geisler, Christian
Jerkeman, Mats
BLOOD, 2016, 128 (14) : 1814 - 1820
[42] Treatment Outcomes and Survival Patterns of Asian Patients With Relapsed/Refractory Mantle Cell Lymphoma
Tan, Jing Yuan
Qiu, Tian Yu
Chiang, Jianbang
Tan, Ya Hwee
Yang, Valerie Shiwen
Chang, Esther Wei Yin
Poon, Eileen
Somasundaram, Nagavalli
Farid, Mohamad
Tao, Miriam
Lim, Soon Thye
Chan, Jason Yongsheng
JOURNAL OF HEMATOLOGY, 2021, 10 (04) : 187 - 195
[43] Effects of Rituximab, Bortezomib, and Bendamustine on the Survival in Medicare Beneficiaries with Mantle Cell Lymphoma
Fu, Shuangshuang
Wang, Michael
Zhao, Hui
Li, Ruosha
Lairson, David
Giordano, Sharon
Zhao, Bo
Du, Xianglin
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S273 - S274
[44] The Age, Comorbidities and Albumin (ACA) Index Is Independently Associated with Overall Survival in Patients with Mantle Cell Lymphoma (MCL)
Akhtar, Othman Salim
Anampa-Guzman, Andrea
Cortese, Matthew J.
Taneja, Alankrita
Aqeel, Sheeba Ba
Ghione, Paola
Hernandez-Ilizaliturri, Francisco
Torka, Pallawi
BLOOD, 2022, 140 : 5160 - 5161
[45] Clinical Significance of Immunohistochemical Markers of Diffuse Large B-Cell Lymphoma In the Rituximab Era.
Hayama, Miyuki
Okamoto, Masataka
Hagiwara, Yuki
Tanae, Ken
Kohri, Mika
Takahashi, Naoki
Yoshino, Tadashi
Ohshima, Koichi
Niitsu, Nozomi
BLOOD, 2010, 116 (21) : 752 - 752
[46] The Percentage of Cytotoxic T-Cells in Mantle Cell Lymphoma (MCL) Biopsies Predicts Response to Rituximab
Opat, Stephen
Farinha, Pedro
Boyle, Merrill
Johnson, Nathalie
OLeary, Hilary
Cook, James R.
Tubbs, Raymond R.
Wang, Lin
Woods, Ryan
Connors, Joseph M.
Gascoyne, Randy D.
BLOOD, 2009, 114 (22) : 1142 - 1143
[47] Trends in Survival Outcomes for Mantle Cell Lymphoma in the Era of Novel Therapies
Ermann, Daniel A.
Vardell, Victoria A.
Fitzgerald, Lindsey
Shah, Harsh
Bock, Allison M.
Stephens, Deborah M.
Hu, Boyu
BLOOD, 2023, 142
[48] A phase III study of ibrutinib in combination with bendamustine and rituximab (BR) in elderly patients with newly diagnosed mantle cell lymphoma (MCL).
Wang, Michael
Gordon, Leo I.
Rule, Simon
Goy, Andre
Hermine, Olivier
Rizo, Aleksandra
Zhuang, Sen Hong
Dreyling, Martin H.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[49] Mantle Cell Lymphoma International Prognostic Score Is Valid and Confirmed in Unselected Cohort of Patients Treated in Rituximab Era
Salek, David
Vasova, Ingrid
Pytlik, Robert
Belada, David
Papajik, Tomas
Kubackova, Katerina
Pimos, Jan
Boudova, Ludmila
Kodet, Roman
Obrtlikova, Petra
Krejcova, Hana
Tmeny, Marek
BLOOD, 2008, 112 (11) : 1283 - 1283
[50] Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial
Kluin-Nelemans, Hanneke C.
Hoster, Eva
Hermine, Olivier
Walewski, Jan
Geisler, Christian H.
Trneny, Marek
Stilgenbauer, Stephan
Kaiser, Florian
Doorduijn, Jeanette K.
Salles, Gilles
Szymczyk, Michal
Tilly, Herve
Kanz, Lothar
Schmidt, Christian
Feugier, Pierre
Thieblemont, Catherine
Zijlstra, Josee M.
Ribrag, Vincent
Klapper, Wolfram
Pott, Christiane
Unterhalt, Michael
Dreyling, Martin H.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (03) : 248 - +

← 1 2 3 4 5 →